Dr. David L. Black earned his undergraduate degree from Loyola College in Baltimore and doctorate degree in Forensic Toxicology from the University of Maryland at Baltimore (1982). He is a Fellow of the American Board of Forensic Toxicology (F-ABFT) and American Institute of Chemists (FAIC). He joined Vanderbilt University in 1986 as Assistant Professor in Pathology and Pharmacology and currently holds appointments in Pharmacology, Pathology, Microbiology and Immunology. In 1990 he founded Aegis Sciences Corporation where he served as Chairman and CEO until October of 2016. He has served as Program Administrator for substance abuse programs for NASCAR, IndyCar, WWE and as a consultant to MLBPA and NFL/NFLPA. He has also served as a consultant to major corporations for development of substance abuse prevention programs. He has testified in local, state, national and international courts as an expert witness regarding drug abuse. He is author of many peer reviewed published scientific papers. He is also President of Ebon-Falcon, LLC (commercial real estate), and Founder/President of 2ndVote. Dr. Black served in the U.S. Marine Corps (1966-70) and in combat in Vietnam (1968-69). Personal interests include church, Rotary International, and Guatemala Medical/Dental/Vision Mission Trips. He lives in Gallatin, TN with his wife former US Congressman Diane Black (TN 6th District) and they have three children and six grandchildren.
Dr. Brooks holds the Wallace D. Malone, Jr. Endowed Chair of Financial Management. He is also founding partner of Blue Creek Investment Partners, LLC, a money management firm (merged with Keel Point, LLC) and president of Financial Risk Management, LLC, a financial risk management consulting firm focused on market risks. Dr. Brooks is the author of over 80 articles appearing in the Journal of Financial and Quantitative Analysis, Journal of Derivatives, Journal of Banking and Finance, Financial Management, and others. Dr. Brooks has been quoted in several print media, including The Wall Street Journal, Bloomberg News, New York Times, and The Bond Buyer. Dr. Brooks has also testified in a subcommittee hearing of the U. S. House of Representatives in Washington, D.C. as well as in a field hearing of the SEC in Birmingham, Alabama.
Dr. Chance, Ph.D., CFA, holds the James C. Flores Endowed Chair of MBA Studies and is Professor of Finance at the E. J. Ourso College of Business at Louisiana State University. He previously held the William H. Wright, Jr. Endowed Chair for Financial Services at LSU, and the First Union Professorship in Financial Risk Management at Virginia Tech. Prior to his academic career, Dr. Chance worked for a large southeastern bank, now part of Regions Bank. He has been a visiting scholar at universities in Hong Kong, Australia, Korea, Singapore, Scotland, and in the U. S. Dr. Chance has had numerous articles published in academic and practitioner journals and has authored four books. He has also been heavily involved in the development and authorship of the derivatives and risk management curriculum in the CFA program. In 2015 he received the C. Stewart Shepard Award for his many years of service to the CFA Institute in the development of its educational programs.
Dr. Michael Edleson, Ph.D., CFA: Dr. Edleson recently retired as Chief Risk Officer, responsible for risk management of The University of Chicago’s endowment. He joined the Office of Investments in early 2010. From 2003–2010, Dr. Edleson ran risk management globally for four divisions of Morgan Stanley as managing director, including CRO for Equities and Morgan Stanley Smith Barney. Previously, he served as Chief Economist and senior vice president of NASDAQ and NASD. Dr. Edleson was a finance professor at Harvard Business School for over six years, following four years on the faculty at West Point; he was an Army engineer officer and served over 29 years in uniform, active and reserve. Dr. Edleson recently served on the board of Financial Management Association International.